| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/21/1999 | CA2296102A1 Triazole compounds and the use thereof as dopamine-d3-ligands |
| 01/21/1999 | CA2296033A1 Novel compounds |
| 01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | CA2295822A1 Novel composition |
| 01/21/1999 | CA2295715A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition |
| 01/21/1999 | CA2295666A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2294752A1 Pak kinase genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2292451A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 01/21/1999 | CA2290038A1 Chaperone fragments |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891365A1 Benzoxazines for enhancing synaptic response |
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
| 01/20/1999 | EP0891358A1 Oxazolidin-2-one derivatives, preparation method therefor and therapeutical use thereof |
| 01/20/1999 | EP0891354A1 N-aminoalkyldibenzofurancarboxamides as dopamine receptor subtype specific ligands |
| 01/20/1999 | EP0891345A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 01/20/1999 | EP0891332A1 6-phenylpyridyl-2-amine derivatives |
| 01/20/1999 | EP0891329A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891328A1 Peptidyl compounds having mmp and tnf inhibitory activity |
| 01/20/1999 | EP0891326A1 Novel vitamin d analogues |
| 01/20/1999 | EP0891322A1 Dimethyl-substituted cyclohexane diene derivatives |
| 01/20/1999 | EP0891188A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 01/20/1999 | EP0871440A4 Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists |
| 01/20/1999 | EP0778775B1 Cosolvent parenteral formulation of tirilazad |
| 01/20/1999 | EP0707579B1 Piperidinyl substituted methanoanthracenes as d1/d2-antagonists and 5ht2-serotanin-antagonists |
| 01/20/1999 | EP0693053B1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/20/1999 | EP0674624B1 Pyrazoles having crf antagonist activity |
| 01/20/1999 | EP0592433B1 Sertindole prodrugs |
| 01/20/1999 | CN1205704A 2,7-substituted octahydro-pyrrolo (1,2-A) pyrazine derivatives |
| 01/20/1999 | CN1205701A Trans apovincaminic acid ester derivatives as drugs |
| 01/20/1999 | CN1205700A Indolenlkyl derivatives of benzodioxanmethylamine as 5-HT1A receptor ligands |
| 01/20/1999 | CN1205641A Administration media for analygesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compsns. containing such media and drugs |
| 01/20/1999 | CN1205335A Tricyclic diazepine vasopression antagonists |
| 01/20/1999 | CN1205205A Pyrazolopyridine compound and processes for preparation thereof |
| 01/20/1999 | CN1041727C Risperidone pamoate salt, its prepn. method and medicinal compsns. containing same |
| 01/20/1999 | CN1041720C Bicyclic amide derivatives, its prepn. method, medicinal compsns. and medical application |
| 01/19/1999 | US5861426 Nitro esters of aromatic compounds with amide or ester groups |
| 01/19/1999 | US5861425 Indole-ethanamines |
| 01/19/1999 | US5861418 Aminobenzoic acid derivatives |
| 01/19/1999 | US5861402 1,4-dihydropyridine compounds |
| 01/19/1999 | US5861401 Treatment of congestive heart failure |
| 01/19/1999 | US5861394 Use of N-substituted phenothiazines |
| 01/19/1999 | US5861179 Treatment of epilepsy |
| 01/19/1999 | CA2166902C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001466A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | WO1999001455A1 Compounds |
| 01/14/1999 | WO1999001454A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | WO1999001452A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | WO1999001451A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | WO1999001448A1 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | WO1999001444A1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine |
| 01/14/1999 | WO1999001439A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | WO1999001438A1 New compounds |
| 01/14/1999 | WO1999001437A1 Compounds |
| 01/14/1999 | WO1999001426A1 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001421A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | WO1999001417A1 (S) 2-METHYLAMINO-2-PHENYL-n-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN |
| 01/14/1999 | WO1999001164A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | WO1999001163A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | WO1999001159A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | WO1999001136A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001135A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 01/14/1999 | WO1999001133A1 Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 01/14/1999 | WO1999001131A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001130A1 Novel substituted imidazole compounds |
| 01/14/1999 | WO1999001123A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | WO1999001122A1 Delayed-release dosage forms of sertraline |
| 01/14/1999 | WO1999001121A1 Sertraline salts and sustained-release dosage forms of sertraline |
| 01/14/1999 | WO1999001113A1 Gelatine encapsulated solution dosage forms of sertraline |
| 01/14/1999 | WO1999001111A1 Stabilized sustained release tramadol formulations |
| 01/14/1999 | DE19728996A1 Triazolverbindungen und deren Verwendung Triazole compounds and the use thereof |
| 01/14/1999 | CA2296014A1 Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists |
| 01/14/1999 | CA2295762A1 Novel cycloalkyl substituted imidazoles |
| 01/14/1999 | CA2295294A1 Cloning pigs using donor nuclei from differentiated cells |
| 01/14/1999 | CA2295228A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2295212A1 Secreted proteins and polynucleotides encoding them |
| 01/14/1999 | CA2294916A1 Cloning using donor nuclei from non-serum starved, differentiated cells |
| 01/14/1999 | CA2294882A1 Compounds |
| 01/14/1999 | CA2294785A1 Low dosed 15-desoxyspergualine preparations |
| 01/14/1999 | CA2294746A1 New compounds |
| 01/14/1999 | CA2294737A1 Lineage-restricted neuronal precursors |
| 01/14/1999 | CA2294734A1 Compounds |
| 01/14/1999 | CA2294524A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294522A1 Novel substituted imidazole compounds |
| 01/14/1999 | CA2294193A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 01/14/1999 | CA2294117A1 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders |
| 01/14/1999 | CA2293324A1 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
| 01/14/1999 | CA2290509A1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
| 01/14/1999 | CA2285479A1 (s) 2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxybenzoate, its application to the treatment of chronic pain |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890105A1 Methods for diagnosing and treating alzheimer's disease |
| 01/13/1999 | EP0889893A1 Azaspiroderivatives |